{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:11:14Z","timestamp":1791389474805,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.critrevonc.2006.11.004","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T07:58:18Z","timestamp":1169539098000},"page":"47-52","source":"Crossref","is-referenced-by-count":88,"title":["Rituximab in the treatment of adult acquired hemophilia A: A systematic review"],"prefix":"10.1016","volume":"63","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2006.11.004_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti CD-20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2141.2004.04836.x","article-title":"Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature","volume":"124","author":"Yomtovian","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib4","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthr Rheum"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.61.10.883","article-title":"Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion","volume":"61","author":"Leandro","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bmt.1703551","article-title":"Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab","volume":"29","author":"Hongeng","year":"2002","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib7","first-page":"189","article-title":"B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia","volume":"87","author":"Zaja","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib8","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","article-title":"Rituximab for the treatment of refractory autoimmune hemolytic anemia in children","volume":"101","author":"Zecca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2141.2001.03078.x","article-title":"Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease","volume":"115","author":"Berentsen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib10","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: a concise review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","article-title":"Treatment of IgM antibody associated polyneuropathies using rituximab","volume":"74","author":"Pestronk","year":"2003","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib14","first-page":"538","article-title":"B-cell compartment as the selective target for the treatment of immune thrombocytopenias","volume":"88","author":"Zaja","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH06-06-0317","article-title":"The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders","volume":"96","author":"Franchini","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2004.04916.x","article-title":"Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia","volume":"125","author":"Mathias","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0950-3536(96)80067-9","article-title":"Acquired inhibitors","volume":"9","author":"Cohen","year":"1996","journal-title":"Bailleres Clin Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2516.2001.00506.x","article-title":"Post-partum acquired haemophilia: clinical recognition and management","volume":"7","author":"Kashyap","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/1097-0142(20010315)91:6<1067::AID-CNCR1101>3.0.CO;2-4","article-title":"Inhibitors against factor VIII in patients with cancer","volume":"91","author":"Sallah","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0037-1963(01)90144-1","article-title":"Inhibitor treatment: state of the art","volume":"38","author":"Shapiro","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2516.2003.00856.x","article-title":"Treatment of acquired haemophilia with factor eight inhibitor bypassing activity","volume":"10","author":"Sallah","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2516.1999.00319.x","article-title":"Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency","volume":"5","author":"Scharrer","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0038-1649664","article-title":"A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies","volume":"70","author":"Green","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-0734.2001.00049.x","article-title":"Acquired hemophilia","volume":"5","author":"Boggio","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1345\/aph.1G658","article-title":"Rituximab in the treatment of acquired hemophilia","volume":"40","author":"Stachnik","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"533a","key":"10.1016\/j.critrevonc.2006.11.004_bib28","article-title":"Treatment of acquired factor VIII deficiency with rituximab","volume":"98","author":"Karwal","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib29","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2002-03-0765","article-title":"Rituximab in the treatment of acquired factor VIII inhibitors","volume":"100","author":"Wiestner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2141.2002.03835_5.x","article-title":"Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab)","volume":"119","author":"Kain","year":"2002","journal-title":"Br J Haematol"},{"issue":"101b","key":"10.1016\/j.critrevonc.2006.11.004_bib31","article-title":"Acquired factor VIII deficiency: rapid and complete remission after immunosuppressive therapy with high dose cyclophosphamide and rituximab","volume":"100","author":"Tamponi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib32","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2002-12-3920","article-title":"Acquired high-titer factor VIII inhibitor: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses","volume":"101","author":"Fischer","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-0609.2003.00038.x","article-title":"Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report","volume":"70","author":"Marietta","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000070973","article-title":"Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab","volume":"109","author":"Jy","year":"2003","journal-title":"Acta Haematol"},{"issue":"101b","key":"10.1016\/j.critrevonc.2006.11.004_bib35","article-title":"Complete remission in high-titre acquired factor VIII inhibitor after rituximab therapy","volume":"102","author":"Low","year":"2003","journal-title":"Blood"},{"issue":"101b","key":"10.1016\/j.critrevonc.2006.11.004_bib36","article-title":"Successful treatment of acquired factor VIII inhibitor with rituximab in four patients","volume":"102","author":"Mazj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib37","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2003-11-4075","article-title":"Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia","volume":"103","author":"Stasi","year":"2004","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.critrevonc.2006.11.004_bib38","article-title":"Successful treatment of acquired haemophilia unresponsive to conventional immunosuppression with rituximab (anti-CD20 antibody)","volume":"10","author":"Grimley","year":"2004","journal-title":"Haemophilia"},{"issue":"Suppl 3","key":"10.1016\/j.critrevonc.2006.11.004_bib39","article-title":"Successful treatment of refractory acquired hemophilia with the anti-CD20 antibody rituximab","volume":"10","author":"Riess","year":"2004","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2006.11.004_bib40","article-title":"Epitope mapping of inhibitory antibodies and inhibitor elimination with rituximab in patients with acquired haemophilia","volume":"3","author":"Krause","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib41","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/j.1538-7836.2005.01611.x","article-title":"Rituximab-induced long-term remission in patients with refractory acquired hemophilia","volume":"3","author":"Abdallah","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2516.2005.01060.x","article-title":"Rituximab for autoimmune haemophilia: a proposed treatment algorithm","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2516.2005.01136.x","article-title":"Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies","volume":"11","author":"Holme","year":"2005","journal-title":"Haemophilia"},{"issue":"4064","key":"10.1016\/j.critrevonc.2006.11.004_bib44","article-title":"Rituximab in the treatment of factor VIII inhibitor","volume":"106","author":"Maruscak","year":"2005","journal-title":"Blood"},{"issue":"3212","key":"10.1016\/j.critrevonc.2006.11.004_bib45","article-title":"Rituximab for the treatment of high titer acquired factor VIII inhibitors refractory to conventional chemotherapy","volume":"106","author":"Field","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2006.11.004_bib46","article-title":"Successful inhibitor elimination with rituximab in acquired hemophilia A and a patient with a carrier status for hemophilia A\u2014two case reports","volume":"3","author":"Hut-Kuhne","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2006.11.004_bib47","article-title":"Successful treatment of acquired haemophilia with FEIBA and rituximab.","volume":"3","author":"Malato","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1160\/TH06-03-0183","article-title":"Rituximab in the treatment of acquired factor VIII inhibitors","volume":"96","author":"Onitilo","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-3148.2006.00669.x","article-title":"Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases","volume":"16","author":"Berezn\u00e9","year":"2006","journal-title":"Transfus Med"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2006.11.004_bib50","article-title":"Efficacy of rituximab treatment in post-partum acquired hemophilia","volume":"12","author":"Santoro","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2006.11.004_bib51","article-title":"Acquired hemophilia following treatment with trimethprim\/sulfamethoxazole in a young woman","volume":"12","author":"Teitel","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2006.11.004_bib52","article-title":"Acquired hemophilia A with severe hematuria and response to rituximab","volume":"12","author":"Theodossiades","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib53","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.ajkd.2006.01.009","article-title":"Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab","volume":"47","author":"Clatworthy","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.critrevonc.2006.11.004_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjmed.2005.06.068","article-title":"Rituximab in post-partum-related acquired hemophilia","volume":"119","author":"Maillard","year":"2006","journal-title":"Am J Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842806002253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842806002253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T19:03:50Z","timestamp":1556046230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842806002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1040842806002253"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2006.11.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}